Abode Biotec India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 7.50 Cr
as on 18-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue 49.29%
(FY 2020)
- Profit -10.62%
(FY 2020)
- Ebitda 93.17%
(FY 2020)
- Net Worth 3337.95%
(FY 2020)
- Total Assets 104.87%
(FY 2020)
About Abode Biotec India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anirudh Lokineni, Prakash Nayaneni, Prakash Naineni, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24296TG2014PTC095216
- Company No.
095216
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2014
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Abode Biotec India?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenadh Madapati  | Director | 25-Oct-2021 | Current |
| Prakash Naineni | Director | 11-Aug-2014 | Current |
| Anirudh Lokineni | Director | 27-Jun-2018 | Current |
| Prakash Nayaneni | Director | 11-Aug-2014 | Current |
| Apurva Naineni | Director | 27-Jun-2018 | Current |
| Ranjith Kalluru | Director | 25-Oct-2021 | Current |
Financial Performance and Corporate Structure Insights of Abode Biotec India.
Abode Biotec India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 49.29% increase. The company also saw a substantial fall in profitability, with a 10.62% decrease in profit. The company's net worth Soared by an impressive increase of 3337.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abode Biotec India?
In 2020, Abode Biotec India had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Abode Drugs Private LimitedActive 16 years 7 monthsPrakash Nayaneni and Prakash Naineni are mutual person
- Hyderabad Logistics (Global) Private LimitedActive 17 years 6 months
Anirudh Lokineni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abode Biotec India?
Abode Biotec India has a workforce of 9 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abode Biotec India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abode Biotec India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
